Ambra Bio

San Diego, United States Founded: 2014 • Age: 12 yrs
Developer of dietary supplements and medical foods
Annual revenue - Latest available
Total funding $1.8M 4 rounds
Employees - Tracked headcount
Investors - Known backers
Products - Services tracked
Competitors 8 Brand Intelligence

About Ambra Bio

Ambra Bio is a company based in San Diego (United States) founded in 2014. Ambra Bio has raised $1.82 million across 4 funding rounds. Ambra Bio operates in a competitive market with competitors including Uute Scientific, WellGen, Filament BioSolutions, Hisun Sulikang Biotechnology and Square Foods, among others.

  • Headquarter San Diego, United States
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Ambra Bioscience Llc
Operational Areas
Healthcare → Nutrition, Wellness & Lifestyle Health Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Total Equity Funding
    $1.82 M (USD)

    in 4 rounds

  • Latest Funding Round
    $1.05 M (USD), Debt – Conventional

    Dec 11, 2017

  • Investors
    Not available
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

People of Ambra Bio

Headcount 10-50
Employee Profiles 1
Board Members and Advisors 5
Employee Profiles
People
Martin R. Brown
CEO

Unlock access to complete

Board Members and Advisors
people
Alain D. Baron
Advisor

Unlock access to complete

Teams

Funding Insights of Ambra Bio

Ambra Bio has successfully raised a total of $1.82M across 4 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $1.05 million completed in December 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

Investments & Acquisitions by Ambra Bio

Investments
Premium access

Investment portfolio details for Ambra Bio

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Ambra Bio

Premium access

Detailed financials for Ambra Bio

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Ambra Bio Comparisons

Ambra Bio Primary company
Description
Developer of dietary supplements and medical foods
Location
San Diego, United States
Founded Year
2014
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for Ambra Bio

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Ambra Bio

Ambra Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Uute Scientific, WellGen, Filament BioSolutions, Hisun Sulikang Biotechnology and Square Foods, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Natural extract products for immune-mediated diseases are provided.
Locked Locked Locked
Medical foods are developed using nutrigenomics and bioinformatics models.
Locked Locked Locked
Therapeutics and medical foods are developed for various diseases.
Locked Locked Locked
Medical foods for digestive disorders are developed and produced.
Locked Locked Locked
Customized early-life nutrition meals are delivered biweekly to homes.
Premium access

Detailed competitors of Ambra Bio

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Ambra Bio

Premium access

Complete news archive for Ambra Bio

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ambra Bio

Ambra Bio was founded in 2014 and raised its 1st funding round 1 year after it was founded.

Ambra Bio is headquartered in San Diego, United States. It is registered at San Diego, California, United States.

Ambra Bio is a funded company, having raised a total of $1.82M across 4 funding rounds to date.

Ambra Bio was founded in 2014 in San Diego, United States, within the biotechnology sector focused on health products. Dietary supplements and medical foods are developed to address metabolic and inflammatory conditions. The Gut Sensory Modulation platform is employed to stimulate L-cell hormone release in the lower gut, influencing hunger, glucose regulation, inflammation, and mood. The primary product, Lovidia, is provided as a supplement for hunger management.

Ambra Bio's top competitors include Uute Scientific, Filament BioSolutions and WellGen.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available